| Literature DB >> 47280 |
L M Fuccella, F Conti, G Corvi, V Mandelli, M Randelli, G Stefanelli.
Abstract
In a double-blind study, indoprofen was superior to placebo in decreasing pain in patients with primary and metastatic cancer and with neuralgia. A single oral dose of 200 mg was more active than a 100-mg dose. The preferences of patients proved to be a more sensitive parameter in this study than scores of pain intensity, pain relief, and other related measurements (SPID, TOTPAR, and Peak PID).Entities:
Mesh：
Substances：
Year: 1975 PMID： 47280 DOI： 10.1002/cpt1975173277
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875